| Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis L Guillevin, C Pagnoux, A Karras, C Khouatra, O Aumaître, P Cohen, ... New England Journal of Medicine 371 (19), 1771-1780, 2014 | 1160 | 2014 |
| 2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the … A Fanouriakis, M Kostopoulou, K Cheema, HJ Anders, M Aringer, ... Annals of the rheumatic diseases 79 (6), 713-723, 2020 | 773 | 2020 |
| Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies A Servais, LH Noël, LT Roumenina, M Le Quintrec, S Ngo, ... Kidney international 82 (4), 454-464, 2012 | 616 | 2012 |
| Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus A Karras, M Lafaurie, A Furco, A Bourgarit, D Droz, D Sereni, C Legendre, ... Clinical Infectious Diseases 36 (8), 1070-1073, 2003 | 478 | 2003 |
| Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up K Dahan, H Debiec, E Plaisier, M Cachanado, A Rousseau, L Wakselman, ... Journal of the American Society of Nephrology 28 (1), 348-358, 2017 | 389 | 2017 |
| Rituximab plus Peg-interferon-á/ribavirin compared with Peg-interferon-á/ribavirin in hepatitis C–related mixed cryoglobulinemia D Saadoun, M Resche Rigon, D Sene, B Terrier, A Karras, L Perard, ... Blood, The Journal of the American Society of Hematology 116 (3), 326-334, 2010 | 331 | 2010 |
| Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled … P Charles, B Terrier, É Perrodeau, P Cohen, S Faguer, A Huart, ... Annals of the rheumatic diseases 77 (8), 1143-1149, 2018 | 323 | 2018 |
| INF2 Mutations in Charcot–Marie–Tooth Disease with Glomerulopathy O Boyer, F Nevo, E Plaisier, B Funalot, O Gribouval, G Benoit, EH Cong, ... New England Journal of Medicine 365 (25), 2377-2388, 2011 | 302 | 2011 |
| Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors L Engelen, I Ferreira, CD Stehouwer, P Boutouyrie, S Laurent, ... European heart journal 34 (30), 2368-2380, 2013 | 286 | 2013 |
| Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis A Karras, C Pagnoux, M Haubitz, K De Groot, X Puechal, JWC Tervaert, ... Annals of the rheumatic diseases 76 (10), 1662-1668, 2017 | 226 | 2017 |
| Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease A Karras, JP Haymann, E Bozec, M Metzger, C Jacquot, G Maruani, ... Hypertension 60 (6), 1451-1457, 2012 | 226 | 2012 |
| Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis F Tamirou, D D'Cruz, S Sangle, P Remy, C Vasconcelos, C Fiehn, ... Annals of the rheumatic diseases 75 (3), 526-531, 2016 | 224 | 2016 |
| Acute renal infarction: a case series M Bourgault, P Grimbert, C Verret, J Pourrat, M Herody, JM Halimi, ... Clinical Journal of the American Society of Nephrology 8 (3), 392-398, 2013 | 223 | 2013 |
| The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases B Terrier, A Karras, JE Kahn, G Le Guenno, I Marie, L Benarous, A Lacraz, ... Medicine 92 (2), 61-68, 2013 | 216 | 2013 |
| Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation M Le Quintrec, A Lionet, N Kamar, A Karras, S Barbier, M Buchler, ... American Journal of Transplantation 8 (8), 1694-1701, 2008 | 215 | 2008 |
| Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature A Karras, E Thervet, C Legendre Transplantation 77 (2), 238-243, 2004 | 214 | 2004 |
| Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome C Melander, M Salle, P Trolliet, S Candon, X Belenfant, E Daugas, P Re, ... Clinical Journal of the American Society of Nephrology 4 (3), 579-587, 2009 | 208 | 2009 |
| Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides B Terrier, C Pagnoux, É Perrodeau, A Karras, C Khouatra, O Aumaître, ... Annals of the rheumatic diseases 77 (8), 1150-1156, 2018 | 206 | 2018 |
| Pathogenic variants in complement genes and risk of atypical hemolytic uremic syndrome relapse after eculizumab discontinuation F Fakhouri, M Fila, F Provôt, Y Delmas, C Barbet, V Châtelet, C Rafat, ... Clinical Journal of the American Society of Nephrology 12 (1), 50-59, 2017 | 196 | 2017 |
| A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial F Tamirou, BR Lauwerys, M Dall'Era, M Mackay, B Rovin, R Cervera, ... Lupus science & medicine 2 (1), e000123, 2015 | 190 | 2015 |
